Trial Profile
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 10 Feb 2022 Status changed from recruiting to completed.
- 07 Oct 2021 Planned End Date changed from 1 Jul 2021 to 1 Dec 2021.
- 08 Oct 2020 Planned End Date changed from 1 Aug 2020 to 1 Jul 2021.